-52%

est. 2Y upside i

Healthcare

A nonprofit stool bank enabling access to fecal transplants.

Rank

#4533

Sector

Biotechnology Research

Est. Liquidity

~0Y

Data Quality

Data: Medium

OpenBiome has transformed into the OpenBiome Foundation, a non-profit health research organization focused on catalyzing microbiome science and advocacy, rather than a commercial entity distributing FMTs.

Last updated: March 10, 2026

Bull (10%)0%

OpenBiome Foundation successfully secures significant grants and partnerships, becoming a leading global catalyst for microbiome research and advocacy, driving scientific breakthroughs and expanding access to therapies. However, as a non-profit, this success does not translate into traditional equity upside for employees.

Base (70%)0%

OpenBiome Foundation maintains its role as a respected non-profit, supporting microbiome research and advocacy through moderate grantmaking and collaborations. The organization remains stable, but without a for-profit commercial model, there is no financial equity upside for employees.

Bear (20%)0%

OpenBiome Foundation faces challenges in securing sufficient funding for its grant programs and advocacy efforts, limiting its impact. Operational shifts and regulatory hurdles continue to strain resources. As a non-profit, this scenario does not result in a traditional equity loss, but rather reduced organizational effectiveness and potential job instability.

Est. time to liquidity~0.0 years

Secondary Liquidity

none

There is no secondary market for equity in a non-profit foundation.

Questions to Ask at the Interview

Strategic questions based on OpenBiome's data — designed to show you've done your homework.

  • 1

    “Given OpenBiome's transformation into a non-profit Foundation, what is the specific nature of the 'equity' (RSUs or options) being offered, and how is its value determined and realized for employees?”

  • 2

    “With the cessation of investigational FMT distribution, how does OpenBiome Foundation plan to sustain and grow its ~$4M historical revenue, and what are the primary funding sources for its new mission-driven activities?”

  • 3

    “What are the long-term strategic goals for OpenBiome Foundation in terms of catalyzing microbiome research and expanding access to therapies, and how does this role differ from that of commercial entities like Ferring or Seres Therapeutics?”

Community

Valuation Sentiment

Our model estimates -52% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.